Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

CARBIDOPA AND LEVODOPA Drug Profile

« Back to Dashboard

What is the patent landscape for Carbidopa And Levodopa, and what generic Carbidopa And Levodopa alternatives are available?

Carbidopa And Levodopa is a drug marketed by Mayne Pharma, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, and Sun Pharma Global. and is included in twenty-three NDAs.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

Summary for Tradename: CARBIDOPA AND LEVODOPA

Patents:0
Applicants:13
NDAs:23
Suppliers / Packagers: see list27
Bulk Api Vendors: see list2
Clinical Trials: see list39,563
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBIDOPA AND LEVODOPA at DailyMed

Pharmacology for Tradename: CARBIDOPA AND LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL075091-001Sep 30, 1999ABRXNoNo► Subscribe► Subscribe
Watson Labs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL073382-001Sep 28, 1993DISCNNoNo► Subscribe► Subscribe
Scs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL074080-001Mar 25, 1994DISCNNoNo► Subscribe► Subscribe
Watson Labs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL073383-001Sep 28, 1993DISCNNoNo► Subscribe► Subscribe
Scs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL074080-002Mar 25, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot